2016 News Articles

All | 2020 | 2019 | 2018 | 2017

Aspirin to Reduce Cancer Risk

In the United States, tens of millions of adults take aspirin to reduce their risk of heart attack or stroke. But studies over the last two decades have suggested that regular use of aspirin may have another important... Read More

POSTED: 12/13/2016

Pile of pills aspirin

In late 2015, the NCI Division of Cancer Prevention convened cancer prevention research experts and stakeholders to discuss the current state of cancer prevention research, identify key prevention research priorities for... Read More

POSTED: 12/13/2016

An illustration depicting three broad phases of tumor development along with driver gene mutations and their pathways, from breakthrough, to expansive, and invasive phases.

RESEARCH UPDATE: ON THE CLINICAL FRONT DNA Methylation Influences the Obesity-Mortality Association in Breast Cancer Overweight and obesity are associated with poor breast cancer (BC) survival.  Previous studies suggest... Read More

POSTED: 10/27/2016

A group of women wearing pink t-shirts holding hands with their arms raised.

TMIST Site Recruitment Begins

ECOG-ACRIN begins site recruitment for TMIST breast imaging trial The Tomosynthesis Mammography Imaging Screening Trial (TMIST), the first large-scale breast cancer screening trial in nearly 25 years, is approved for... Read More

POSTED: 10/25/2016

Study Confirms Benefits of Early Palliative Care for Advanced Cancer

Patients who received palliative care along with standard treatment for advanced cancer reported having a better quality of life and mood than patients who did not receive early palliative care, according to the results of a... Read More

POSTED: 10/05/2016
SOURCE: NCI Cancer Currents

Many Cancer Caregivers Report Feeling Unprepared for Caregiving Challenges

Many family members who care for loved ones with cancer do not feel adequately prepared for the caregiving tasks they assume and need help to make informed decisions about end-of-life care, according to a new study. Read More

POSTED: 09/27/2016
SOURCE: NCI Cancer Currents

Olanzapine Helps Prevent Nausea and Vomiting Caused by Chemotherapy

A drug currently used to treat several psychiatric conditions can help prevent nausea and vomiting in patients receiving chemotherapy, according to results from a large NCI-funded phase III clinical trial. Read More

POSTED: 07/21/2016
SOURCE: NCI Cancer Currents

The NCI has awarded 18 grants to continue the Early Detection Research Network (EDRN), a national infrastructure that supports the integrated development, validation, and clinical application of biomarkers for the early... Read More

POSTED: 07/18/2016

The Early Detection Research Network has helped 6 cancer diagnostic tests achive FDA approval.

The Interactive Diet and Activity Tracking in AARP (IDATA) Study is a methodologic study of device-based, internet-based, and conventional self-report instruments for assessing physical activity and diet in epidemiologic... Read More

POSTED: 06/20/2016

IDATA logo.

The application period for investigators interested in obtaining biospecimens and data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial re-opened June 1. A separate application for obtaining... Read More

POSTED: 06/02/2016

Screen grab of the new PLCO Website.

Launch of The National MDS Study

The National Myelodysplastic Syndromes Natural History Study (The National MDS Study) is underway, the ECOG-ACRIN Cancer Research Group and its collaborators announced today. Read More

POSTED: 05/25/2016
SOURCE: ECOG-ACRIN Cancer Research Group

Online Tool Helps Users Distinguish Moles from Melanoma

As Melanoma/Skin Cancer Detection and Prevention Month comes to a close and summer begins, NCI has launched a new online tool called Moles to Melanoma: Recognizing the ABCDE Features. Read More

POSTED: 05/23/2016
SOURCE: NCI Cancer Currents

Image of a computer screen dispalying the NCI meanoma tool.

Teams of scientists around the world are working to develop ways to detect early signs of ovarian cancer in blood. Considerable progress has been made in understanding the disease, but as yet there are no proven... Read More

POSTED: 05/19/2016

The application period for the NCI Cancer Prevention Fellowship Program (CPFP) is open. Since 1987, CPFP has provided funding support for post-doctoral Fellows to train the next generation of researchers and leaders in the... Read More

POSTED: 05/12/2016

Title frame of the Cancer Prevention Fellowship Program video.

After Rising for Decades, Thyroid Cancer Incidence Stabilizes

After rising steadily for decades, the incidence of thyroid cancer in the United States may have stabilized, according to a new study. Although still increasing, the number off new cases has risen at a much slower rate in... Read More

POSTED: 05/06/2016
SOURCE: NCI Cancer Currents

Worta McCaskill-Stevens, M.D., M.S., Chief of the Community Oncology and Prevention Trials Research Group, NCI Division of Cancer Prevention, was named the recipient of the 2016 American Association for Cancer Research... Read More

POSTED: 04/15/2016

Portrait of NCORP Director Worta McCaskill-Stevens,  M.D..

Aspirin Recommended for Colorectal Cancer Prevention Only in Those with Risk for Heart Disease

The U.S. Preventive Services Task Force (Task Force) published a final recommendation statement and evidence summaries on the use of aspirin for the primary prevention of cardiovascular disease and colorectal cancer. The... Read More

POSTED: 04/13/2016
SOURCE: U.S. Preventive Services

Pile of pills aspirin

Drug Combination Shrinks Duodenal Polyps in People with Familial Adenomatous Polyposis

In a small clinical trial of people with an inherited condition that greatly increases the risk of developing gastrointestinal cancers, a two-drug combination has been shown to shrink duodenal polyps, precursor lesions for... Read More

POSTED: 04/07/2016
SOURCE: NCI Cancer Currents

Endoscopic view of polyps

Blue Ribbon Panel announced to help guide Vice President Biden’s National Cancer Moonshot Initiative

Today, the National Cancer Institute (NCI), part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates that will inform the scientific direction... Read More

POSTED: 04/04/2016
SOURCE: NCI Press Release

Blue Ribbon Panel

The National Cancer Institute’s Division of Cancer Prevention has released a new funding opportunity to solicit organ-specific applications for Biomarker Developmental Laboratories (BDLs), one of the four scientific units... Read More

POSTED: 03/18/2016

Information on Patients and the NCI-MATCH Trial Process Updated

Updated information is available about patients and the process in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) clinical trial. The NCI-MATCH trial has two enrollment steps. Each patient initially enrolls for... Read More

POSTED: 03/07/2016
SOURCE: NCI Clinical Trials Information

Driving New Approaches to Cancer Prevention and Early Detection

Research into the prevention and early detection of cancer is entering a new era. With our greater understanding of how cancers develop and, far too often, flourish—and with the availability of powerful new technologies—our... Read More

POSTED: 01/13/2016
SOURCE: NCI Cancer Currents

Image of DCP Leadership in a meeting